Biomaterials in cardiopulmonary bypass
- 1 January 1994
- journal article
- research article
- Published by SAGE Publications in Perfusion
- Vol. 9 (1) , 3-10
- https://doi.org/10.1177/026765919400900102
Abstract
The improved utilization of biomaterials in cardiopulmonary bypass is dependent on polymer science and technology, procedures for blood compatibility assessment, optimization of biomaterial/antithrombotic agent combinations and the interpretation of clinical data.Keywords
This publication has 59 references indexed in Scilit:
- Cardiovascular BiomaterialsPublished by Springer Nature ,1992
- Biomaterials in Artificial OrgansPublished by Springer Nature ,1984
- Biocompatible Polymers, Metals, and CompositesJournal of Clinical Engineering, 1983
- Low dose aspirin and inhibition of thromboxane B2 production in healthy subjectsThrombosis Research, 1980
- Relationship between Secretion of Platelet Factor 4 and Thrombin Generation during In Vitro Blood ClottingJournal of Clinical Investigation, 1980
- Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfacesBlood, 1980
- The complexity of blood at simple interfacesJournal of Colloid and Interface Science, 1978
- SURFACE‐INDUCED PLATELET ADHESION, AGGREGATION, AND RELEASE*†Annals of the New York Academy of Sciences, 1977
- The Adhesion of Platelets to Subendothelium, Collagen and Artificial SurfacesSeminars in Thrombosis and Hemostasis, 1976
- Thrombin adsorption and possible relations to thrombus formationJournal of Biomedical Materials Research, 1969